SEQUENCE: Risankizumab doubles endoscopic remission rates compared with ustekinumab in CD Presented ByProf. Laurent Peyrin-Biroulet, University Hospital of Nancy, France TrialPhase 3, SEQUENCE ConferenceUEGW 2023 TypePeer-reviewed article 7 December 2023 15:44